Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Cumulative Antigen Suppression Reduces Clonal Plasma Cell Evolution in Gaucher Disease.
Journal: American journal of hematology
Published: May 27, 2026
Real-World Efficacy and Safety of Standard-of-Care Chimeric Antigen Receptor T-Cell (CART) and Bispecific T-Cell Engager (TCE) Therapies in Relapsed/Refractory Multiple Myeloma (RRMM).
Journal: European journal of haematology
Published: April 29, 2026
Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community Network.
Journal: Cancers
Published: April 03, 2026
Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison.
Journal: Advances in therapy
Published: October 03, 2025
Immune effector cell-associated enterocolitis post-BCMA directed CAR T-cell therapy: insights from a multicenter case series.
Journal: Blood cancer journal
Published: July 30, 2025
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison.
Journal: Current medical research and opinion
Published: August 12, 2024
Aiming for the cure in myeloma: Putting our best foot forward.
Journal: Blood reviews
Published: March 20, 2023
Association of iron infusion reactions with ABO blood type.
Journal: European journal of haematology
Published: June 03, 2022
Autologous hematopoietic stem cell product contaminated with Salmonella due to occult salmonellosis in an asymptomatic donor.
Journal: Journal of clinical apheresis
Published: September 28, 2021
Last Updated: 09/26/2026